Stocks and Investing Stocks and Investing
Mon, June 7, 2021
Fri, June 4, 2021

Andrew Berens Maintained (AZN) at Buy with Increased Target to $64 on, Jun 4th, 2021


Published on 2024-10-27 16:54:06 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "AstraZeneca PLC" (AZN) at Buy with Increased Target from $63 to $64 on, Jun 4th, 2021.

Andrew has made no other calls on AZN in the last 4 months.



There are 3 other peers that have a rating on AZN. Out of the 3 peers that are also analyzing AZN, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Monday, April 12th, 2021


These are the ratings of the 2 analyists that currently disagree with Andrew


  • Peter Welford of "Jefferies" Upgraded from Hold to Strong Buy on, Tuesday, March 16th, 2021
  • Michael Leuchten of "UBS" Upgraded from Hold to Strong Buy on, Thursday, February 25th, 2021
Contributing Sources